Clinical Rigor for Commercial ExcellenceNovember 9th, 2017 | Posted by in Life Sciences and Healthcare
By Scott Beauchamp, Vice President in Client Services, APT
For decision-makers across industries, optimizing commercial strategies is critical. More and more organizations are adopting a robust analytic approach – and life sciences companies have a distinct advantage. Because clinical trials are an integral part of your business, you are already familiar with leveraging test vs. control methodology to measure the true impact of new initiatives.
Read on to learn more about how life sciences companies are expanding the power of experimentation beyond the lab, to help them make more informed, data-driven decisions. We include a case example of how one brand team improved the ROI of their NPP investments by over 10x by using a Test & Learn approach.
You can follow any responses to this entry through the RSS 2.0 Both comments and pings are currently closed.